Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Contributed by: Business Wire

Tags

Science

Biotechnology

Research

Pharmaceutical

Alternative Medicine

Health

Mental Health

Clinical Trials

Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

More Like This

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Two Investor Conferences in December

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights